Beruflich Dokumente
Kultur Dokumente
Industry Players Covered – 8 [ All SE-Listed Players (Constituting 80 % of the Industry Size) ]
Percentage Contribution by each of the Listed Player to industry Sales & EBIDTA over last
5 Years
Percentage Contribution by each of the Listed Player to industry Sales & EBIDTA
(Q1'FY11 over Q1'FY10)
Current Valuation Commanded by each of the Listed Company (execept GAEL & EICL)
based on price as on 13th August 2010
Last 10 Years' Sales, EBIDTA, OP & NP Performance of Each of the Listed Company
Last 10 Years' Expenditure Trend of Each of the Listed Company (except GAEL & EICL)
Last 10 Years' Expenditure Viewed w.r.t. Sales & EBIDTA (of 3 Top Listed Companies)
Last 9 Quarters' Sales, EBIDTA, OP & NP Performance of Each of the Listed Company
Last 9 Quarters' Expenditure Trend of Each of the Listed Company (except GAEL & EICL)
Last 9 Quarters' Expenditure Viewed w.r.t. Sales & EBIDTA (of 3 Top Listed Companies)
Brief Textual Overview & Analysis of the Industry asto Why It will Start Carving its Place in
Every Portfolio meant for Growth
Q1FY11 Q1FY10
Q1FY11 Q1FY10
(in ` cr.)
Sales 745.61 533.99 333.15 355.87 248.15 198.87 158.81 115.48 92.83
EBIDTA 119.91 61.5 54.62 54.33 33.09 25.28 22.5 18.5 11.66
Operatin 95.69 46.78 42.01 43.46 24.88 17.56 15.24 12.67 8.5
g Profit
Net 39.21 13.98 19.93 26.76 11.34 3.95 1.5 1.26 2.33
Profit
(in ` cr.)
FY10 FY09 FY'08 FY'07 FY'06 FY'05 FY'04 FY'03 FY'02 FY'01
(in ` cr.)
Sales 259.27 203.69 181.48 162.96 122.88 91.83 80.12 68.74 61.14 61.73
EBIDTA 31.95 24.82 31.14 31.5 13.6 8.64 8.03 8.54 7.91 8.01
Operatin 26.01 19.71 27.89 28.64 11.2 6.63 6.13 6.99 6.56 6.81
g Profit
Net 14.67 11.6 20.15 20.7 6.46 2.66 2.47 3.56 3.48 3.31
Profit
(in ` cr.)
(in ` cr.)
(in ` cr.)
(in ` cr.)
(in ` cr.)
(in ` cr.)
Deprec. 24.22 14.72 12.61 10.87 8.21 7.72 7.26 5.83 3.16
Finan. 20.82 27.17 12.49 10.91 11.89 12.19 12.37 10.37 5.96
Expenses
Tax 37.21 7.17 9.58 5.52 1.57 1.32 1.34 0.99 0.21
(in ` cr.)
FY10 FY09 FY'08 FY'07 FY'06 FY'05 FY'04 FY'03 FY'02 FY'01
(in ` cr.)
Deprec. 5.94 5.11 3.25 2.86 2.4 2.01 1.9 1.55 1.35 1.2
Finan. 7.09 5.39 4.63 3.18 3.23 2.86 2.66 2.23 2.02 2.6
Expenses
Tax 4.23 2.71 3.1 4.75 1.5 1.1 1 1.2 1.05 0.9
(in ` cr.)
(in ` cr.)
(in ` cr.)
Yearly Expenditure viewed with respect to Sales and EBIDTA of Riddhi Siddhi
Deprec. 3.24 2.75 3.78 3.05 3.3 3.88 4.57 5.04 3.4
(% Sales)
Fin. Exp. 17.36 44.17 22.86 20 35.93 48.21 54.97 56.05 51.11
(%
EBIDTA)
Tax 31.03 11.65 17.53 10.16 4.74 5.22 5.95 5.35 1.8
(%
EBIDTA)
Yearly Expenditure viewed with respect to Sales and EBIDTA of Anil Products
Yearly Expenditure viewed with respect to Sales and EBIDTA of Sukhjit Starch
FY10 FY09 FY'08 FY'07 FY'06 FY'05 FY'04 FY'03 FY'02 FY'01
(in %)
Deprec. 2.29 2.5 1.79 1.75 1.95 2.18 2.37 2.25 2.2 1.94
(% Sales)
Fin. Exp. 22.19 21.71 14.86 10.09 23.75 33.1 33.12 26.11 25.53 32.45
(%
EBIDTA)
Tax 13.23 10.91 9.95 15.07 11.02 12.73 12.45 14 13.27 11.23
(%
EBIDTA)
Last 10 Years' Margin Scenario of Top 3 Listed Companies
EBIDTA 16.08 11.51 16.39 15.26 13.33 12.71 14.16 16.02 12.56
Margins
OPM 12.83 8.76 12.6 12.21 10.02 8.82 9.59 10.97 9.15
NPM 5.25 2.61 5.98 7.51 4.56 1.98 0.94 1.09 2.5
FY10 FY09 FY'08 FY'07 FY'06 FY'05 FY'04 FY'03 FY'02 FY'01
(in %)
EBIDTA 12.32 12.18 17.15 19.32 11.06 9.4 10.02 12.42 12.93 12.97
Margin
OPM 10.03 9.67 15.36 17.57 9.11 7.21 7.65 10.16 10.72 11.03
NPM 5.65 5.69 11.1 12.7 5.25 2.89 3.08 5.17 5.69 5.36
Last 9 Quarters' Sales, EBIDTA, OP & NP Performance of Each of the Listed Company
(in ` cr.)
Sales 202.76 231.26 193.58 164.43 156.33 161.53 124.05 126.01 122.4
EBIDTA 44.97 49.09 28.68 23.42 18.7 5.11 15.19 20.79 21.18
Operating 39.49 38.72 24.41 18.79 13.76 3.89 10.94 16.59 17.13
Profit
Net Profit 27.4 12.13 12.77 9.15 5.14 3.5 1.26 1 8.22
(in ` cr.)
Sales 106.41 102.24 96.57 90.23 85.53 87.06 81.32 57.29 53.35
EBIDTA 19.27 18.47 13.96 10.7 9.26 11.07 8.54 4.61 6.24
Operating 17.75 17.12 12.53 9.46 8.11 9.76 7.57 3.64 5.28
Profit
Net Profit 8.82 7.52 7.15 5.33 3.98 4.26 3.89 0.86 1.5
(in ` cr.)
Sales 78.89 73.02 69.17 58.16 57.85 51.57 52.62 50.22 49.04
EBIDTA 13.65 13.2 7.68 5.7 4.8 4.88 5.42 6.74 7.61
Operating 12.15 11.7 6.48 4.45 3.55 3.38 4.22 5.84 6.71
Profit
Net Profit 8.54 7.13 4.03 2.3 1.81 1.34 2.05 3.8 4.81
(in ` cr.)
Sales 93.49 94.63 91.01 73.26 78.77 58.86 54.65 47.82 52.7
EBIDTA 16.74 16.16 9.02 7.73 8.11 5.25 1.11 4.72 3.86
Operating NA NA NA NA NA NA NA NA NA
Profit
Net Profit NA NA NA NA NA NA NA NA NA
Quarterly Performance of English Indian Clays (Starch Division)
(in ` cr.)
Sales 40.44 44.66 39.09 36.47 39.12 35.43 37.98 35.08 39.12
EBIDTA NA NA NA NA NA NA NA NA NA
Operating 2.98 3.44 1.53 1.56 2.04 0.37 1.81 1.93 2.04
Profit
Net Profit NA NA NA NA NA NA NA NA NA
(in ` cr.)
Sales 26.87 25.8 18.74 18.44 21.19 18.34 18.91 18.01 18.71
EBIDTA 3.41 3.92 -0.27 -0.46 2.31 -0.37 0.15 0.35 1.24
Operating 2.53 3.08 -1.05 -1.24 1.53 -1.17 -0.65 -0.45 0.44
Profit
Net Profit 1.27 1.41 -0.5 -0.7 0.49 -0.97 -1.05 -1.02 -0.43
Sales 19.22 20.01 15.19 14.01 12.42 11.82 11.44 11.74 11.88
EBIDTA 1.87 3.69 0.36 0.45 0.77 0.14 -0.01 -0.23 0.15
Operating 1.11 2.95 -0.37 -0.28 0.05 -0.56 -0.73 -0.95 -0.55
Profit
Net Profit 0.75 2.6 -0.59 -0.4 -0.11 -0.73 -0.93 -1.06 -0.61
(in ` cr.)
Sales 12.01 11.91 11.3 11.91 11.55 10.92 9.91 10.77 10.44
EBIDTA 1.34 0.5 0.66 0.75 1.56 1.19 0.06 0.63 1.04
Operating 1.14 0.3 0.46 0.58 1.34 0.9 -0.11 0.47 0.87
Profit
Net Profit 1 -0.26 0.21 0.36 1.08 0.59 -0.36 0.16 0.56
Last 9 Quarters' Sales, EBIDTA, OP & NP Growth % of Top 3 Listed Companies
Sales -12.32 19.46 17.73 5.18 -3.22 30.21 -1.55 2.95% 122.4
EBIDTA -8.39 71.16 22.46 25.24 265.95 -66.36 -26.94 -1.84 21.18
Operating 1.99 58.62 29.91 36.56 253.73 -64.44 -34.06 -3.15 17.13
Profit
Net Profit 125.89 -5.01 39.56 78.02 46.86 177.78 26 -87.83 8.22
Sales 4.07 5.87 7.03 5.5 -1.76 7.06 41.94 7.39 49.04
EBIDTA 4.33 32.31 30.47 15.55 -16.35 29.62 85.25 -26.12 7.61
Operating 3.67 36.63 32.45 16.65 -16.91 28.93 107.97 -31.06 6.71
Profit
Net Profit 17.28 5.17 34.15 33.92 -6.57 9.51 352.33 -42.67 4.81
(in ` cr.)
Deprec. 5.48 10.37 4.27 4.63 4.95 2.22 4.25 4.2 4.05
Finan. 4.52 4.09 4.81 5.78 6.14 -1.67 7.79 13.77 6.13
Expenses
Tax 8.18 23.26 7.1 4.29 2.56 1.33 1.89 1.82 2.78
(in ` cr.)
Deprec. 1.52 1.35 1.43 1.24 1.15 1.31 0.97 0.97 0.96
Finan. 6.52 5.79 4.11 3.27 2.76 2.53 2.93 2.47 2.47
Expenses
Tax 2.41 3.8 1.26 0.86 1.36 2.96 0.75 0.3 0.9
(in ` cr.)
Deprec. 1.5 1.5 1.2 1.25 1.25 1.5 1.2 0.9 0.9
Finan. 1.69 2.55 1.71 1.55 1.24 1.44 1.32 1.64 1.15
Expenses
Tax 2 2.25 0.9 0.8 0.5 0.6 0.85 0.5 0.65
(in ` cr.)
Deprec. 0.88 0.84 0.78 0.78 0.78 0.8 0.8 0.8 0.8
Finan. 0.75 0.5 0.52 0.71 0.62 0.64 0.7 0.77 0.8
Expenses
Tax 0.51 1.17 -0.03 -0.33 0.42 0.1 -0.3 -0.2 0.07
Quarterly Expenditure Trend of Gayatri Bioorganics
(in ` cr.)
Deprec. 0.76 0.74 0.73 0.73 0.72 0.7 0.72 0.72 0.7
Finan. 0.53 0.34 0.21 0.11 0.17 0.14 0.2 0.11 0.05
Expenses
Tax 0 0 0 0 0 0 0 0 0
(in ` cr.)
Deprec. 0.2 0.2 0.2 0.17 0.22 0.29 0.17 0.16 0.18
Finan. 0.14 0.25 0.14 0.19 0.24 0.31 0.24 0.29 0.29
Expenses
Tax 0 0.25 0.1 0 0 0 0 0 0
Last 9 Quarters' Expenditure Viewed w.r.t. Sales & EBIDTA (of 3 Top Listed Companies)
Quarterly Expenditure viewed with respect to Sales and EBIDTA of Riddhi Siddhi
Deprec. 2.7 4.48 2.21 2.82 3.17 1.37 3.43 3.33 3.31
(% Sales)
Fin. Exp. 10.05 8.33 16.77 24.68 32.83 -32.68 51.28 66.23 28.94
(%
EBIDTA)
Tax 18.19 47.38 24.76 18.32 13.69 26.02 12.44 8.75 13.13
(%
EBIDTA)
Quarterly Expenditure viewed with respect to Sales and EBIDTA of Anil Products
Deprec. 1.42 1.32 1.48 1.37 1.34 1.5 1.19 1.69 1.8
(% Sales)
Fin. Exp. 33.83 31.35 29.44 30.56 29.81 22.85 34.31 53.58 39.58
(%
EBIDTA)
Tax 12.51 20.57 9.03 8.04 14.69 26.74 8.78 6.51 14.42
(%
EBIDTA)
Quarterly Expenditure viewed with respect to Sales and EBIDTA of Sukhjit Starch
Deprec. 1.9 2.05 1.73 2.15 2.16 2.91 2.28 1.79 1.84
(% Sales)
Fin. Exp. 12.38 19.32 22.27 27.19 25.83 29.51 24.35 24.33 15.11
(%
EBIDTA)
Tax 14.65 17.05 11.72 14.04 10.42 12.3 15.68 7.42 8.54
(%
EBIDTA)
Last 9 Quarters' Margin Scenario of Top 3 Listed Companies
EBIDTA 22.17 21.22 14.81 14.24 11.96 3.16 12.24 16.49 17.3
Operating 19.47 16.74 12.6 11.42 8.8 2.41 8.81 13.16 13.99
Profit
Net Profit 13.51 5.24 6.59 5.56 3.28 2.16 1.01 0.79 6.71
EBIDTA 18.11 18.06 14.45 11.86 10.82 12.71 10.5 8.04 11.69
Margins
OPM 16.68 16.74 12.97 10.48 9.48 11.21 9.3 6.35 9.89
NPM 8.28 7.35 7.4 5.9 4.65 4.89 4.78 1.5 2.81
EBIDTA 17.3 18.07 11.1 9.8 8.29 9.46 10.3 13.42 15.51
Margins
OPM 15.4 16.02 9.36 7.65 6.13 6.55 8.01 11.62 13.68
NPM 10.82 9.76 5.82 3.95 3.12 2.59 3.89 7.56 9.8
Brief Textual Overview & Analysis of the Industry asto Why It will Start Carving its Place in
Every Portfolio meant for Growth
With a current Industry size (Organised) of ` 2082.17 cr. and a 15 % p.a. growth
expected till 2015, Starch & Starch Derivatives is an industry commanding a definite place
in any growing portfolio. It is not the sheer size but the pace of achievement of such size
which deserves an attention. Over the last five years, industry has grown at a CAGR of 21.8
% from a meager ` 880.99 cr. in FY06 to the current ` 2082.17 cr. in FY10. To add, this
growth in size is coupled with a strong cash generation which is evident from the fact that
EBIDTA of the industry has grown at a CAGR of 41 % from a meager ` 79.42 cr. in FY06
to ` 273.67 cr. in FY10. This growth in EBIDTA is achieved inspite of the fact that the
price of the main input of the industry viz., maize, which constitutes 65 % cost for the
industry, has almost doubled in last five years. This trend depicts a widening of the
marketplace for the industry as well as the ability of the industry players to command
pricing environment of their products. With a stable pricing scenario expected for maize in
coming few years and factors like :
➢ high price of sugar prompting need to search for its alternatives, especially in Food
& Beverages Industry,
➢ extremely low per capita starch consumption in India which is less than 1 kg. as
compared to US where it is 64 kg. and global average which is at 6 kg.,
➢ emergence of starch as an environment-friendly alternative to plastics in many
applications like carry-bags,
➢ use of starch in innovative applications like manufacture of ethanol and
biodegradable plastics, etc.
Riddhi Siddhi Gluco Biols Ltd. is an industry by itself rather than an industry player.
It is this company which has contributed tremendously towards the growth of Starch &
Starch Derivatives industry and has brought the industry to such a level that it is hard to
imagine a growth portfolio without the presence of this industry.
To talk in financial terms, if we take into account just last five financial years,
Riddhi has swelled its topline by a whooping 200.40 % vis-a-vis industry which has swelled
its topline by 136.34 %. On EBIDTA front too, Riddhi has swelled it by 262.37 % vis-a-vis
industry EBIDTA which swelled by 244.58 % over last five years. Riddhi enjoys a 35 %
market share of the industry and is an undisputed leader of the industry. A strategic equity
stake of 14.95 % by world's 4th largest cornstarch producer Roquette adds visibility to
Riddhi's leadership status remaining undisputed for many many years to come.
Rather than going into other details, here we will only briefly discuss the financial
terms of Riddhi. On financial front, Riddhi is a very strong company with almost the entire
investment phase having got concluded with the commisioning of 30 % additional capacity
at Rudrapur plant in June 2010. Going forward we can see a significant reduction in debt
position of Riddhi because of the healthy cash generated by it in FY10 and expected
robust cash that will get generated in FY11. Q1FY11 was a curtain-raiser to this with
expansion of OPM by 1067 basis points YoY and 270 basis points QoQ. In the same
quarter, Riddhi expanded its NPM by 1022 basis points YoY and 829 basis points QoQ. For
FY11, Riddhi is expected to achieve an EBIDTA margin of 17.5-18.5 % on a topline of `
1056 cr. with an EPS of ` 77.60. FY12 will see its expanded capacity attaining a utilisation
level 85 % + which will see its topline getting swelled to ` 1380 cr.
One important point to note regarding the quality of earnings of Riddhi is the fact
that its depreciation and tax charge has consistently been much higher than all the peers
including Anil Products and Sukhjit Starch while its EBIDTA margins have traditionally
been better than all its peers.
At the current market price of ` 391.65, Riddhi is trading at a P/E of 5.04 based on
FY11E EPS of ` 77.60 and at a P/E multiple of just 4.63 based on FY12E EPS of ` 84.50
(after factoring in an equity dilution in FY12). This is the cheapest valuation at which one
can get the leader of an industry which by itself is growing at 15 % + and the company
which has consistent track record of last ten years of outperforming the industry by quite a
wide margin. Hence, Riddhi is a strong rerating candidate and the safest bet for the Starch
& Starch Derivatives industry and untill the time it adjusts its valuation and starts trading
at a historical multiple band of 8-8.5 its FY11E EPS, it will retain a 'Safe Buy” status.
Anil Products Ltd. - An Industry Performer
Anil Products can best be described as an 'Industry Performer' which will grow its
topline inline with the industry while outperforming the industry in terms of EBIDTA.
Over last five financial years, Anil swelled its topline by 118.34 % which is lower than the
growth of industry topline which swelled by 136.34 % over the same period. However, Anil
managed a swelling of 315.53 % in EBIDTA over last five years which is far ahead of the
industry EBIDTA which got swelled by 244.58 %. This is because the company's main focus
has always been value-added products which command a higher margin. However, with a
three-fold capacity expansion planned in next 3 years, this scenario could very well change
and the company is expected to grow its topline inline or ahead of the industry topline.
Margins could take a hit as company will enter into an investment phase over the next 2-3
years which could very well see it underperforning Riddhi and Sukhjit.
At the current market price of ` 196.70, Anil trades at a P/E multiple of 5.21 based
on its FY11E EPS of ` 37.75 (FY11E Topline – ` 455 cr.). After Riddhi, Anil will command
the 'Second-Best Buy' status for the Starch & Starch Derivatives industry.
Sukhjit Starch & Chemicals Ltd. - A Consistent Performer
Inspite of underperforming the industry on topline and EBIDTA front over the span
of last five years, Sukhjit has managed to trade at higher valuation than all its peers
including the leader Riddhi is because of the fact that it has a low floating stock and
consistent bottomline performance over last many years. Lets look in number terms,
Sukhjit swelled its topline by 111 % which is lower than the industry topline which got
swelled by 118.34 % over the last five years. On EBIDTA front too, Sukhjit swelled it by
134.92 % which is far lower than the industry EBIDTA which got swelled by 244.58 % over
the last live years' period. With the robust Q1FY11 numbers posted as well as a capacity
expansion planned, Sukhjit could very well perform inline with the industry topline growth
while its underperformance on EBIDTA front could also very well continue. However,
because of the low floating stock and limited options available to invest in the sunrise
sector of Starch & Starch Derivatives, Sukhjit could very well continue to trade at a
premium to Riddhi and Anil in the near future but over the medium term it is expected to
show underperformance vis-a-vis Riddhi valuation and perform at par with Anil's valuation.
In the medium term, Riddhi's valuation is expected to correct itself higher to trade at a
premium to Sukhjit's and Anil's valuation after which, based on the expansion attained by
the industry valuation, Sukhjit's investment rationale will need to be reassesed.
Gujarat Ambuja Exports Ltd. - A Dark Horse
'Risk' is the best word to describe investment into Universal Starch which might
eventually turn out to be a surprise winner but, when you have industry's top companies
available at single digit P/E multiples, why take such unnecessary risks. It is last two
quarters' performance which merits a status of 'Possible Risky Winner' status for Universal
Starch, but, if you look at its past trackrecord, it is best to avoid it till the time it proves
itself. Since already a sharp run-up has already taken place in the valuation of Universal
Starch, at a P/E multiple of 8.83 based on its FY11E EPS of ` 4.76, it is best to reasses the
investment decision into it at a later stage once expansion of valuation of entire industry
takes place.
If we term Universal Starch as 'Risk' then Gayatri and Tirupati are a complete
'Avoid' at this stage as Riddhi, Anil and Sukhjit are far superior bets for Starch & Starch
Derivatives industry available at attractive valuation at the current stage. Hence, when we
are at a stage where the industry has just started carving its place in every portfolio meant
for growth, top 3 companies will give much better returns than bottom 3 companies.